期刊文献+

RamR突变协同靶位基因GyrA突变调控RamA表达水平的研究 被引量:1

Mutations in RamR together with mutations in GyrA played important roles in regulation of RamA expression
原文传递
导出
摘要 为了探讨RamR突变类型及对RamA表达调控的影响,靶位突变与外排泵过表达之间的关联,从临床分离的34株沙门菌中筛选不同RamR突变类型菌株,通过外排泵能量抑制(CCCP)试验和有机溶剂耐受试验(OST)验证外排泵的活性,构建不同RamR突变类型的质粒,互补到RamR野生型突变菌株中,采用RT-PCR方法检测各菌株RamA的表达水平。结果表明,15株ramR存在4种突变类型:M83T(n=6),A37S(n=3),T18P(n=3)和氨基酸的缺失(n=3)。CCCP抑制试验和OST试验证实,15株菌株中有10株存在明显的有活力的外排泵作用,4株存在活力微弱的外排泵。RamR三种氨基酸突变类型都上调了RamA的表达水平。靶位基因GyrA第83位的突变协同RamR的A37S或M83T突变均可引起RamA的表达显著增强,而T18P突变没有明显影响。相反,GyrA第87位的突变协同RamR的A37S或M83T突变则下调RamA的表达水平。本研究表明,所有的RamR的突变都可引起RamA表达水平增高,RamR与靶位基因突变协同调控RamA的表达水平,协同GyrA第83位突变可明显促进RamA的表达,而协同GyrA第87位突变则下调RamA的表达。 Salmonella strains with mutations in RamR were screened from 34 clinical isolates,and the efflux activity of the mutants was further detected by efflux pump inhibition assay with CCCP and organic solvent tolerance test(OST). The rareR-complementing plasmids of mutants were constructed and trans- formed into wild type rarer strains harboring single mutation in position 83 or 87 in GyrA. Reverse tran- scription-PCR was used to assess the expression of ramA of various complementary strains. Total of 4 types of mutations within ramR among 15 of 34 Salmonella strains,including M83T(n= 6), A37S(n= 3), T18P(n=3) and nucleotide deletions(n=3). Active or weak efflux pumps were detected by CCCP and OST assays. Both mutation types were associated with up regulation of expression of RamA. A single mutation at posi- tion 83 within GyrA combined with mutation A37S or M83T in RamR enhanced the expression of RamA. By con- trast,a single mutation of GyrA 87 together with RamR mutation decreased the expression of RamA.
出处 《中国兽医科学》 CAS CSCD 北大核心 2013年第11期1200-1205,共6页 Chinese Veterinary Science
基金 国家自然科学基金资助项目(31272602)
关键词 沙门菌 外排泵 反转录-聚合酶链反应 QRDR Salmonella efflux pump reverse transcription-PCR QRDR
  • 相关文献

参考文献19

  • 1ELENAA F, CARLOS A C, CAMINO G F, et al. Prevalence and antimicrobial resistance of Salmonella serotypes isolated from poultry in Spain: comparison between 1993 and 2006[J]. Int J Food Microbiol, 2012,153(3) : 281-287.
  • 2SHIN H, LEE J H, LIM J A,et al, Complete genome sequence of Salmonella enterica serovar Typhimurium bacteriophage SPNIS[J]. J Virol,2012,86(2) :1284-1285.
  • 3HOPKINS K L, DAVIES R H, THRELFALL E J, et al.Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments [J]. Int J Antimicrob Agents, 2005,25 (5) : 358-373.
  • 4SYLVIE B, ELISABETHI C D, AXEL C. Role of TolC and parC mutation in high-level fluoroquinolone resistance in Sal- monella enterica serotype Typhimurium DT204[J].J Antimi- crob Chernother, 2004,53 (4) : 657-659.
  • 5ASAKO H, NAKAJIMA H, KOBAYASHI K,et al. Organic solvent tolerance and antibiotic resistance increased by over- expression of marA in Escherichia coli [J]. Appl Environm Microbiol, 1997,63 (4) : 1428-1433.
  • 6ETIENNE G, AXEL C, DOMINIQUE K, et al. Evidence for active efflux as the primary mechanism of resistance to cipro- floxacin in Salmonella enterica serovar Typhimurium [J].Antimicrob Agents Chemother , 2000,44(5) : 1223-1228.
  • 7NIKAIDO H,PAGES J M. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria [J]. FEMS Microbiol Rev, 2012,36(2) : 340-363.
  • 8ABOUZEED Y M, BAUCHERON S, CLOECKAERT A, et al. rareR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium[J].Antimicrob Agents Chemother , 2008,52 (7) : 2428-2434.
  • 9SYLVIE B, SHAUN T, DAVID B, et al. AcrAB-TolC directs efflux-mediated multidrug resistanee in Salmonella enterica se- rovar Typhimurium DT104[J]. Antimicrob Agents Chemother , 2004,48(10) :3729-3735.
  • 10NIKAIDO E, YAMMAGUCHI A, NISHINO A, et al. AcrAB multidrug efflux pump regulation in Salmonella enterica sero- var Typhimurium by RamA in response to environmental sig- nals[J]. J Biol Chem ,2008,283(35) :24245-24253.

二级参考文献16

  • 1Majowicz S E,Musto J,Scallan E, et al. The global burden ofnontyphoidal Salmonella gastroenteritis [J ]. Clin. Infect Dis,2010, 50C6):882-889.
  • 2Guerrant R L, Van Gilder T,Steiner T S. et al. Practiceguidelines for the management of infectious diarrhea[J]. ClinInfect Dis, 2001,32(3) :331-351.
  • 3Baucheron S. E, Chaslus-Dancla, A. Cloeckaert. Role of TolCand parC mutation in high-level fluoroquinolone resistance inSalmonella cntcrica serotype Typhimurium DT204[J]. J Anti-microb Chemother, 2004,53(4) :657-659.
  • 4Baucheron S,Imberechts H,Chaslus-Dancla E,et al. TheAcrB multidrug transporter plays a major role in high-level flu-oroquinolone resistance in Salmonella enterica serovar typhi-murium phage type DT204[J]. Microb Drug Resist, 2002,8(4):281-289.
  • 5Giraud E,Cloeckaert A, Kerboeuf D,et al. Evidence for ac-tive efflux as the primary mcchanism of resistance to ciproflox-acin in Salmonella enterica serovar typhimurium[J]. Antimi-crob Agents Chemother, 2000, 44(5) : 1223-1228.
  • 6Chen S,Cui S,McDermott P F, et al. Contribution of targetgene mutations and efflux to decreased susceptibility of Salmo-nella enterica serovar typhimurium to fluoroquinolones and oth-er antimicrobialvs[J]. Antimicrob Agents Chemother,2007,51(2):535-542.
  • 7Datsenko K A, B L Wanner. One-step inactivation of chromo-somal genes in Escherichia coli K-l2 using PCR products[J],Proc Natl Acad Sci USA, 2000,97(12) : 6640-6645.
  • 8VGiraud E,Brisabois A,Martel J L, et al. Comparative stud-ies of mutations in animal isolates and experimental in vitro-and in vivo'selected mutants of Salmonella spp. suggest acounterselection of highly fluoroquinolone-resistant strains inthe fie3d[J]. Antimicrob Agents Chemother, 1999,43(9):2131-2137.
  • 9Clinical and Laboratory Standards Institute. PerformanceStandards for Antimicrobial Susceptibility Testing[G]. 2007.
  • 10Hsueh P. R,Teng L J , Tseng S P,et al. Ciprofloxacin-re-sistant Salmonella enterica Typhimurium and Choleraesuisfrom pigs to humans, Taiwan[J]. Emerg Infect Dis,2004,10(l):60-68.

共引文献2

同被引文献22

  • 1贺奋义.沙门氏菌的研究进展[J].中国畜牧兽医,2006,33(11):91-95. 被引量:42
  • 2付晓平.靶位突变与外排泵机制对动物源沙门菌耐药性的影响[Z].2013.
  • 3Abouzeed Y M,Baucheron S,Cloeckaert A.RamR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium[J].Antimicrob Agents Chemother,2008,52(7):2428-2434.
  • 4Akiyama T,Khan A A.Molecular characterization of strains of fluoroquinolone-resistant Salmonella enterica serovar schwarzengrund carrying multidrug resistance isolated from imported foods[J].J Antimicrob Chemother,2012,67(1):101-110.
  • 5Asperilla M O,Smego R J,Scott L K.Quinolone antibiotics in the treatment of Salmonella infections[J].Rev Infect Dis,1990,12(5):873-889.
  • 6Eaves D J,Randall L,Gray D T,et al.Prevalence of mutations within the quinolone resistance-determining region of gyrA,gyrB,parC,and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica[J].Antimicrob Agents Chemother,2004,48(10):4012-4015.
  • 7Giraud E,Cloeckaert A,Kerboeuf D,et al.Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium[J].Antimicrob Agents Chemother,2000,44(5):1223-1228.
  • 8Hansen H,Heisig P.Topoisomerase Ⅳ mutations in quinolone-resistant Salmonellae selected in vitro[J].Microb Drug Resist,2003,9(1):25-32.
  • 9Hopkins K L,Davies R H,Threlfall E J.Mechanisms of quinolone resistance in Escherichia coli and Salmonella:Recent developments[J].Int J Antimicrob Agents,2005,25(5):358-373.
  • 10Kehrenberg C,Cloeckaert A,Klein G,et al.Decreased fluoroquinolone susceptibility in mutants of Salmonella serovars other than Typhimurium:Detection of novel mutations involved in modulated expression of ramA and soxS[J].J Antimicrob Chemother,2009,64(6):1175-1180.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部